Literature DB >> 16439574

Expression of the TGF-beta family of ligands is developmentally regulated in skeletal muscle of neonatal rats.

Agus Suryawan1, Jason W Frank, Hanh V Nguyen, Teresa A Davis.   

Abstract

To dissect the possible role of the transforming growth factor-beta (TGF-beta) family in the regulation of skeletal muscle growth during the early postnatal period, the protein abundances of the TGF-beta family and their correlation with protein synthesis were determined in skeletal muscle of neonatal rats. To obtain direct evidence of the role of these growth factors in the regulation of protein synthesis, the TGF-beta inhibitor, follistatin, was infused into 10-d-old rats for 11 d and protein synthesis and phosphorylation of S6 kinase 1 (S6K1) and ribosomal protein (rpS6) were measured. TGF-beta2 abundance and protein synthesis in muscle decreased with development and were positively correlated. The abundances of bone morphogenetic protein 2 (BMP-2), BMP-7, and myostatin increased with development and were negatively correlated with protein synthesis. The abundances of BMP-2 and BMP-7 were positively correlated with BMP receptor IA (BMP-RIA) abundance. Activin A abundance was positively correlated with follistatin abundance and activin receptor IIB (Act-RIIB) abundance. Infusion of follistatin increased muscle protein synthesis and S6K1 and rpS6 phosphorylation. The results provide indirect and direct evidence of TGF-beta family involvement in the regulation of muscle protein synthesis during the neonatal period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439574     DOI: 10.1203/01.pdr.0000196718.47935.6e

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

1.  Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.

Authors:  Samuel M Cadena; Kathleen N Tomkinson; Travis E Monnell; Matthew S Spaits; Ravindra Kumar; Kathryn W Underwood; R Scott Pearsall; Jennifer L Lachey
Journal:  J Appl Physiol (1985)       Date:  2010-05-13

2.  Myogenic growth factors can decrease extraocular muscle force generation: a potential biological approach to the treatment of strabismus.

Authors:  Brian C Anderson; Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

3.  Identification of differentially regulated secretome components during skeletal myogenesis.

Authors:  C Y X'avia Chan; Olena Masui; Olga Krakovska; Vladimir E Belozerov; Sebastien Voisin; Shaun Ghanny; Jian Chen; Dharsee Moyez; Peihong Zhu; Kenneth R Evans; John C McDermott; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2011-02-22       Impact factor: 5.911

4.  Ribosome abundance regulates the recovery of skeletal muscle protein mass upon recuperation from postnatal undernutrition in mice.

Authors:  Marta L Fiorotto; Teresa A Davis; Horacio A Sosa; Carolina Villegas-Montoya; Irma Estrada; Ryan Fleischmann
Journal:  J Physiol       Date:  2014-09-19       Impact factor: 5.182

5.  Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice.

Authors:  Stephen Welle; Kerri Burgess; Sangeeta Mehta
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

6.  Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

Authors:  Sean L McGee; Kirsty J Mustard; D Grahame Hardie; Keith Baar
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

Review 7.  Regulation of muscle growth in neonates.

Authors:  Teresa A Davis; Marta L Fiorotto
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

8.  Identification of a novel transforming growth factor-beta (TGF-beta6) gene in fish: regulation in skeletal muscle by nutritional state.

Authors:  Bruria Funkenstein; Elena Olekh; Sonia B Jakowlew
Journal:  BMC Mol Biol       Date:  2010-05-12       Impact factor: 2.946

9.  Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.

Authors:  Caroline Barbé; Stéphanie Kalista; Audrey Loumaye; Olli Ritvos; Pascale Lause; Benjamin Ferracin; Jean-Paul Thissen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-28       Impact factor: 4.310

Review 10.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.